The Future of Pharma: Evolutionary Threats and Opportunities
The Future of Pharma examines the causes of the industry's potential decline and offers a convincing and rigorous analysis of the options open to it. What emerges is a landscape defined, on the one hand, by the changing marketplace of mass-market consumers, institutional healthcare systems and...
Sábháilte in:
| Príomhchruthaitheoir: | |
|---|---|
| Formáid: | LEABHAR |
| Teanga: | Béarla |
| Foilsithe / Cruthaithe: |
London
Routldge An Imprint of Taylor & Francis Group
2016
|
| Ábhair: | |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
MARC
| LEADER | 00000nam a22000007a 4500 | ||
|---|---|---|---|
| 008 | 220124b ||||| |||| 00| 0 eng d | ||
| 952 | |0 0 |1 0 |2 ddc |4 0 |6 338_476151000000000_SMI |7 0 |9 12499 |a 50008178 |b 50008178 |d 2021-10-28 |e Pharma Book Syndicate Hyderabad |g 4642.97 |l 0 |o 338.476151 SMI |p JP001693 |r 2023-08-25 00:00:00 |w 2022-01-24 |y RB | ||
| 999 | |c 7011 |d 7011 | ||
| 020 | |a 9781138247499 | ||
| 082 | |a 338.476151 |b SMI | ||
| 100 | |a Smith, Brian D. |9 7705 | ||
| 245 | |a The Future of Pharma: Evolutionary Threats and Opportunities | ||
| 260 | |a London |b Routldge An Imprint of Taylor & Francis Group |c 2016 | ||
| 300 | |a xviii, 194 p. | ||
| 520 | |a The Future of Pharma examines the causes of the industry's potential decline and offers a convincing and rigorous analysis of the options open to it. What emerges is a landscape defined, on the one hand, by the changing marketplace of mass-market consumers, institutional healthcare systems and wealthy individuals; and on the other by the alternate sources of commercial value - innovative therapies; super-efficient processes, supply chains and operations; and closer customer relations and increasingly tailored health services. | ||
| 650 | |a Pharmaceutical Industry |9 7522 | ||
| 650 | |a Pharmaceutical Industry - Forecasting |9 7522 | ||